X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 11c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.72), $0.11 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day
• Premarket movers: Oracle surges on AI growth, ACV auctions jumps on $1.9B deal